跳至主要内容
临床试验/ACTRN12624000332527
ACTRN12624000332527尚未招募Unknown

Investigation of hyper-excretion of cefazolin as a potential cause of treatment failure in patients with invasive bacterial infection

niversity of Otago0 个研究点目标入组 10 人开始时间: 2024年3月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Abnormally low plasma cefazolin concentration despite standard dosing and/or cefazolin treatment failure not easily explained by an alternative cause
  • Age greater than or equal to 18 years
  • Resolution of index infection
  • Provision of informed consent to participate in the study
  • Able to comply with study procedures

排除标准

  • Prior adverse reaction to cefazolin or any of its excipients
  • Poor venous access
  • Most recent haemoglobin concentration below 110g/L for women or 115g/L for men
  • Receipt of cefazolin within the last 7 days

研究者

相似试验